WeVote

Bill

Bill

LR 142

Recognize May 2025 as Myositis Awareness Month in Nebraska

109th Legislature (2025-2026) Introduced by Machaela Cavanaugh

Nebraska designates May 2025 as Myositis Awareness Month to raise awareness among Nebraskans, health professionals, and policymakers; no new funding or programs.

Adopted
0
WeVote Research Nonpartisan
Bill Summary · LR 142

Summary: Legislative Resolution LR 142 – Myositis Awareness Month (Nebraska)

Purpose and Intent

  • LR 142 is a nonbinding legislative resolution recognizing May 2025 as Myositis Awareness Month in Nebraska.
  • The resolution expresses support for all individuals affected by myositis, a group of rare, inflammatory muscle diseases.

Key Provisions

  • Recognizes May 2025 as Myositis Awareness Month in Nebraska, aligning with a nationwide observance organized by The Myositis Association.
  • States Nebraska residents are among those affected by myositis and other rare diseases.
  • Emphasizes the need for heightened awareness, knowledge, and understanding of myositis among the public, healthcare providers, and policymakers.
  • Acknowledges that myositis is often difficult to diagnose, with delayed treatment and challenges finding qualified healthcare providers.
  • Highlights that research is needed to identify causes and treatments, and notes that people with myositis may experience reduced quality of life and shortened life expectancy.
  • Addresses health disparities, noting that women and people of color with myositis face particularly pronounced disparities.
  • Declares support for all people affected by myositis and the goals of the Myositis Association, a leading international patient advocacy organization focused on patient services, education, research, and public awareness.

Note: As a resolution, the bill does not create new programs, funding, or statutory requirements; its impact is ceremonial and informational, aimed at raising awareness and solidarity.

Affected Parties

  • Nebraskans living with myositis and other rare inflammatory muscle diseases.
  • Healthcare providers and the broader Nebraska health community (for awareness and education purposes).
  • The general public, through heightened awareness and understanding of myositis.

Background and Context

  • Myositis encompasses idiopathic inflammatory myopathies that cause chronic muscle inflammation and weakness, pain, fatigue, swallowing difficulties, and can include interstitial lung disease.
  • The Myositis Association is described as the leading international patient advocacy organization for this condition.

Procedural Timeline

  • Introduced: April 30, 2025 (LR 142, 109th Legislature, First Session).
  • Laid over: April 30, 2025 (initial consideration).
  • Adopted: May 7, 2025.
  • Signature: President/Speaker signed on or around May 7, 2025, finalizing adoption.

Sponsors

  • Primary sponsor: M. Cavanaugh.

Potential Impact

  • Elevates visibility of myositis within Nebraska.
  • Encourages public education and awareness among Nebraskans and health professionals.
  • May support future policy discussions or funding decisions related to rare diseases and neuromuscular health, though LR 142 itself does not authorize spending or new programs.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.